Although hepatic IRS-1 mRNA levels did not differ among the four groups (Supplementary Figure 2a), hepatic IRS-2 mRNA levels were significantly lower in subjects with simple steatosis, borderline-NASH and NASH than in those with no steatosis (Supplementary Figure 2b). This evidence concerns the gene IRS2 and metabolic dysfunction-associated steatohepatitis.